U.S. markets closed

Tetra Bio-Pharma Inc. (TBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.1850-0.0050 (-2.63%)
At close: 3:59PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in CAD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/16/2021
Current
2/28/202111/30/20208/31/20205/31/20202/29/2020
Market Cap (intraday) 5
68.11M55.65M52.51M53.55M60.59M96.83M
Enterprise Value 3
70.05M55.15M41.45M37.03M48.62M91.26M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
659.00N/AN/AN/AN/A620.24
Price/Book (mrq)
4.212.461.551.331.753.33
Enterprise Value/Revenue 3
755.75N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-2.89-6.58-5.75-7.67-11.09-20.08

Trading Information

Stock Price History

Beta (5Y Monthly) 1.97
52-Week Change 3-34.48%
S&P500 52-Week Change 345.08%
52 Week High 30.3700
52 Week Low 30.1350
50-Day Moving Average 30.1896
200-Day Moving Average 30.1928

Share Statistics

Avg Vol (3 month) 32.36M
Avg Vol (10 day) 3922.62k
Shares Outstanding 5358.47M
Implied Shares Outstanding 6N/A
Float 254.37M
% Held by Insiders 19.62%
% Held by Institutions 10.14%
Shares Short (Mar 30, 2021) 4409.29k
Short Ratio (Mar 30, 2021) 40.13
Short % of Float (Mar 30, 2021) 4N/A
Short % of Shares Outstanding (Mar 30, 2021) 40.11%
Shares Short (prior month Feb 25, 2021) 49.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Nov 29, 2020
Most Recent Quarter (mrq)Nov 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.23%
Return on Equity (ttm)-89.56%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -20.45M
Net Income Avi to Common (ttm)-21.15M
Diluted EPS (ttm)-0.1030
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.5M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2M
Total Debt/Equity (mrq)8.85
Current Ratio (mrq)0.53
Book Value Per Share (mrq)0.08

Cash Flow Statement

Operating Cash Flow (ttm)-19.64M
Levered Free Cash Flow (ttm)-11.26M